Biotech firm Windtree Therapeutics announced plans to purchase up to $700 million in BNB after the cryptocurrency reached a new all-time high of $808. The company, trading on Nasdaq under the ticker WINT, intends to utilize up to $520 million to fund these acquisitions, following an earlier commitment of $200 million. To facilitate these purchases, Windtree will partner with the crypto exchange Kraken for asset custody and will raise funds through an equity line of credit and a stock-purchase agreement with Build and Build Corp. Despite a recent 5% decline in stocks, Windtree saw a significant 162% increase over the past month. This move aligns with a growing trend of publicly traded companies acquiring digital assets beyond Bitcoin, as seen with other firms like Nano Labs and Strategy. Windtree's CEO emphasized the importance of these funds in bolstering their cryptocurrency strategy.

Source šŸ”—